Following the agreement of the GMS contract for 2019/20, please find attached the Directions to Local Health Boards as to the Statement of Financial Entitlements (Amendment) (No. 2) Directions 2019. The amending Direction –
• enables the revised Global Sum figure of £90.00 to be applied from 1 July; and
• for a backdated Global Sum monthly payment of £3.25 to be applied per weighted patient for the period from 1 April 2019 to 30 June 2019 to be paid at the end of July.
As part of the GMS agreement, other amendments are required to the Statement of Financial Entitlements which will follow in due course.
Gwasanaethau Meddygol Cyffredinol - General Medical Services
Yr Is-adran Gofal Sylfaenol - Primary Care Division
Cyfarwyddiaeth Gofal Sylfaenol a Gwyddor Iechyd - Directorate of Primary Care & Health Science
Iechyd a Grwp Gwasanaethau Cymdeithasol - Health and Social Services Group
Llywodraeth Cymru - Welsh Government
Ffon - Tel: 03000 255684
I am writing to let you know formally that I am standing down from my position of Chair of Gwent LMC at the end of June however I am pleased to announce that
Dr Gareth Oelmann will be taking over the Chair of the LMC from 01/07/19.
I will remain as his Deputy Chair to complete my elected term (March 2021) and then hope to emulate my previous Chairman Dr Neil Statham in an ex-officio position.
This change in position is to support the LMC’s succession planning strategy during these challenging times for our profession.
I am pleased that the LMC has grown in strength over the past 4 years and we have a dynamic representation for the GPs in Gwent with active communication with our constituents and have built on the relationships forged by my predecessors with colleagues at ABUHB, leading to increased communication and consultation.
I have thoroughly enjoyed being the Chair of the LMC and look forward to continuing to be actively involved in the Gwent LMC in years to come.
While Cardiff & Vale University Health Board (CVUHB) are establishing the Welsh Gender Team, the London Gender Identity Clinic (GIC) will continue to offer appointments to new patients from Wales. We can confirm that all Welsh patients who have been referred to the London GIC remain on their waiting list. Your cases are open and you have not been discharged. Both Welsh Health Specialised Services and CVUHB acknowledge that there has been some confusion and would like to apologise for any recent misunderstanding or anxiety that may have been caused around the status of your appointments and where you might be seen.
Whilst we are not yet in a position to confirm the start date of the new service in Wales, we hope to be able to do so very shortly. The Welsh Gender Team has taken longer to set up than we anticipated, and we appreciate the frustrations this is causing. We would like to apologise for this, and thank you for your patience during this time. We hope that you understand that CVUHB believe it is essential to have the right mix of skills and expertise in place in order to be able to open the clinic. Until CVUHB is in a position to formally announce the start date, we wish to reiterate that the current pathway CP21 and referral process remain in place.
Tra bod Bwrdd Iechyd Prifysgol Caerdydd a'r Fro (BIPC) yn sefydlu Tîm Rhyw Cymru, bydd Clinig Hunaniaeth Rhyw Llundain (THR) yn parhau i gynnig apwyntiadau i gleifion newydd o Gymru. Gallwn gadarnhau bod yr holl gleifion o Gymru sydd wedi cael eu hatgyfeirio i THR Llundain yn dal ar eu rhestr aros. Mae eich achosion ar agor ac nid ydych wedi cael eich rhyddhau. Mae Gwasanaethau Iechyd Arbenigol Cymru a BIPC yn cydnabod y bu rhywfaint o ddryswch a hoffem ymddiheuro am unrhyw gamddealltwriaeth diweddar neu bryder a achoswyd o amgylch statws eich apwyntiadau a ble y gallech gael eich gweld.
Er nad ydym mewn sefyllfa eto i gadarnhau dyddiad dechrau'r gwasanaeth newydd yng Nghymru, rydym yn gobeithio gallu gwneud hynny'n fuan iawn. Mae Tîm Rhyw Cymru wedi cymryd mwy o amser i'w sefydlu nag yr oeddem wedi'i ragweld, ac rydym yn gwerthfawrogi'r rhwystredigaethau y mae hyn yn ei achosi. Hoffem ymddiheuro am hyn, a diolch am eich amynedd yn ystod y cyfnod hwn. Gobeithiwn eich bod yn deall bod BIPC yn credu ei bod yn hanfodol cael y cymysgedd iawn o sgiliau ac arbenigedd yn eu lle er mwyn gallu agor y clinig. Hyd nes bod BIPC mewn sefyllfa i gyhoeddi'r dyddiad cychwyn yn ffurfiol, hoffem ailadrodd bod y llwybr presennol CP21 a'r broses atgyfeirio yn parhau yn eu lle.
Please see attached updated BMA Cymru Wales ‘Focus on’ document regarding the State-backed GP indemnity scheme for Wales.
Grateful if you could redistribute and share.
Committee executive officer (GPC Wales)/Swyddog gweithredol pwyllgorau
BMA Cymru Wales
You have received flu vaccination guidance from PHW suggesting first and second choice vaccines for different age groups.
We suspect that this is “balanced” to avoid PHW being accused of promoting one company over another.
The “CHOICE” is really yours as a clinician.
No vaccine is blacklisted so you are free to choose the vaccine that best suits your practice.
Whilst GPCW cannot encourage anyone to use the enhanced vaccine that is twice the price of the others (and we have been given no evidence of clinical scenarios where it might prove preferable), there is considerable evidence in support of cellular vaccine.
It is quadrivalent
Virtually all strains of flu virus can be covered
It has minimal antigenic shift
It is relatively easy to quickly produce in bulk.
It contains no egg.
It is effective from age 9 upwards
As we have always encouraged practices to spread their orders over two suppliers, we would leave that choice to you, but note that the egg cultured quadrivalent vaccine covers four strains and has effectiveness under the age of 65.
The majority of children from 2 – 11 will receive the live intranasal quadrivalent vaccine – Fluenz, directly supplied by WG.
Under 2’s at risk and those children unable to receive live vaccine the egg based Quadrivalent vaccine may be used.
Vaccination and Immunisation Lead GPCW
Page 6 of 21